Paris, France

Axelle Solignac

This inventor holds 2 USPTO granted patents. Top assignees: Sanofi-Synthelabo, Synthelabo. Active years: 1999-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Axelle Solignac. Retrieved from https://idiyas.com/inventor/axelle-solignac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Axelle Solignac: Innovator in Pharmaceutical Chemistry

Introduction

Axelle Solignac is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development efforts. With a total of 2 patents, her work has garnered attention in the scientific community.

Latest Patents

Among her latest patents are the development of 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives and 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives. These inventions showcase her expertise in creating novel compounds with potential applications in medicine.

Career Highlights

Axelle has worked with notable companies such as Synthelabo and Sanofi-Synthelabo. Her experience in these organizations has allowed her to refine her skills and contribute to various projects that advance pharmaceutical research.

Collaborations

Throughout her career, Axelle has collaborated with esteemed colleagues, including Samir Jegham and Alistair Lochead. These partnerships have enriched her work and fostered a collaborative environment for innovation.

Conclusion

Axelle Solignac stands out as a talented inventor in the pharmaceutical industry. Her contributions through her patents and collaborations highlight her commitment to advancing scientific knowledge and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…